Antisoma Share Discussion Threads

[cumnor] 18/2/2011 11:14

The mgmt review and slash, along with perhaps a plan to move forward in bio or divest the remaining portfolio will no doubt be nearly ready, hastened no doubt by the presence of a new, possibly un-sympathetic shareholder like Ora on board. Will help to concentrate the mind. Ora are in this for profit, whatever plan they have.

This should underpin the share price at the 2.25 level at least imo. Would'nt surprise me to see mgmt trying something with Rnvo, creating a very well funded, very lean bio with buying power, a wider portfolio and a much leaned down cost base, hq, management and skilled workforce which could add significant value to the combined group. Biotechs and pharmas are out of favour I know. This is where being cash rich can lead to nice pickings, as the cycle will turn. imo dyor and wishful thinking.

[bobbobbington] 16/2/2011 14:03

Then why not invest in a fund? A biotech with cash but no products is no better than a VC.

[kmjs] 16/2/2011 09:41

Bob

That article underlines the fact that cash is still very much King in this
sector. There are a number of avenues open to the likes of ASM/RNVO purely
because of their current cash balances.

IMO, ASM/RNVO should now shelve their own pipeline (at least for the time
being) and buy one of the more promising tiny biotechs that have recently
announced noteworthy advances in their products, IF they would still have
a reasonable amount of cash left to progress the company further, or maybe
look to merge with the likes of SLN who are larger, but would certainly seem
in need of that size cash injection.

[mike111d] 15/2/2011 22:00

Does PWhite still believe that GE is going to become and E&P guru overnight - LOL.

[the_doctor] 15/2/2011 15:34

sure

but would that generate value?

given ASM's track record IMO if they acquired something, most investors wouldnt want to price in the cash or the IP

[kmjs] 15/2/2011 13:38

Well, there are plenty of other bio's out there desperate for cash and it
is not beyond the realms of possibility that ASM could use their money to
buy something promising and IF needs be shelve their own remaining pipeline.

Be interesting to see what finally happens here and it would seem RNVO are
also in a similar position.

[the_doctor] 15/2/2011 13:22

Bear in mind that there are scenarios in which Ora might not want to make any money with these holdings directly, but just control the vote.
ie. own 30% at 2.4p ave and you could really help push through a reverse takeover with terms at 2.5p say.
The net result would be holders would hold shares in a speculative biotech investment valued at 2.5p/share... and as SLN shows, that can then drop significantly

[cumnor] 15/2/2011 13:13

Not yet, but they are paying a lot more than they needed to last week which suggests they have an agenda which is more than just mere speculation. If they see the value others might start to. imo

[the_doctor] 15/2/2011 13:09

Note they're not paying over 2.5p
That could be significant IMO

[cumnor] 15/2/2011 13:03

Ora picking stock agian, patiently biding time rather than leaping in and getting it at well below nav(which is way more than cash discounting termination costs). Interesting to see how this fits in with mgmts agenda as they head for the high twenties and whether a white knight in the form of some US Bio might be invited to join the party. These guys have the contacts and IP. imo

[the_doctor] 14/2/2011 13:16

PWhite - I was posting to highlight the idiotic comment that biotechs would deliberately fail trials that could have made them 100s millions IF they'd gone right.

'None of these microcap AIM biotech stocks have the remotest chance of making any impact on the fight against cancer.'
dont be daft. They have as much chance as any when in Phase III
The greater investment in Phase II just stops you going into Phase III if its not worth it
I dont think you realise that Big Pharma PIIs are not 'large and diverse' or a program costing £100 millions

[freddie ferret] 14/2/2011 12:45

We know a lot is going on. Management have said that they will shorty be issueing a RNS on slimming the board and employees, we have also been told anecdotally that since the announcements the phone has not stopped ringing to the CEO.
A lot of rubbish is being talked as if this were a cash shell, it is not and I do not see anybody being allowed to reverse into it unless the terms were very good. Still the derampers see little in this company apart from some cash. That is wrong there are, other products to be developed or licensed, a large stash of intellectual property and patents, an experienced and capable management team with the money available to do new things.
For the time being we wait on what management is doing and announcements it will make.

[pwhite73] 11/2/2011 22:07

the_doctor - 11 Feb'11 - 20:36 - 5613 of 5613

'this a deliberate tactic' eh? deliberately fail trials that could have earned them £100ms???'

£100ms..what!. None of these microcap AIM biotech stocks have the remotest chance of making any impact on the fight against cancer. Let's get real.

The reason why the Phase III trials fail is because they do not have the £100 millions required to do a proper Phase II trial on a large and diverse enough sample of people across the globe.

[pwhite73] 11/2/2011 22:07

Double post.

[the_doctor] 11/2/2011 20:36

'this a deliberate tactic'
eh?
deliberately fail trials that could have earned them £100ms???


'All this talk of winding up costs I believe to be nonsense'
nobody has said that. It's primarily about the existing liabilities on the books!



'A business valued at £50 million would gladly reverse into ASM to have a cash balance at some 40% of its market capital.'
yeah, sure. So what?
What makes you think you'd get a better portion of that new entity than the remainder cash pile would buy?
moreover, what makes you think the new business would perform well?
It could just spend through all the cash as ASM has done

[polygram] 11/2/2011 20:16

Would have been a decent buy at 2.3p but would not want to pay more.

[pwhite73] 11/2/2011 19:43

the_doctor

I am in agreement with you on one thing and that is ORA or whoever will reverse another business into ASM. ORA have increased their stake again today. I am expecting the announcement of corporate action tranforming the business shortly.

A business valued at £50 million would gladly reverse into ASM to have a cash balance at some 40% of its market capital. All this talk of winding up costs I believe to be nonsense. It costs nothing to wind a business up as on most occasions this activity is done when a company has completely run out of money.

Renova are in the same situation as of the day. The cynic in me says is this a deliberate tactic by cash rich British Pharmas to extract themselves from essentially risky and cash demanding businesses. Is time being eventually called on the British biotech industry.

[serious] 11/2/2011 19:15

Lol clubman !!!!!

[clubman] 11/2/2011 16:08

You left out Cheryl Cole.

[freddie ferret] 11/2/2011 16:02

Clubman.
I have done some thinking and I now believe I have done you an injustice.
That you talk twaddle I still believe is beyond doubt.
However I entered into a personal attack on you which I now appologise for, sorry I was unkind and judgemental you are entitled to hold and express your view right or wrong.
No doubt you did leave school at 15 and then built up a small empire in the drink and club trade.
For what it is worth I went to a secondary modern school and as such saw the development of many such as you.
There were IMHO four main reasons for kids leaving school early.
First they may have been thick.
Second they came from bad home lives.
Third they were delinquent and were in with the wrong friends.
Fourth bullying or the results of earlier bullying.

It is now generally believed that the human brain continues to develop long after school in fact 40 years old seems to be being touted now as the cut off point. There are many people that have done badly at school but have gone on to be sussessfull in later life, Sir Rannolph Feinnes and Alan Sugar come to mind.

[clubman] 11/2/2011 09:16

WTF teaboy

[the_doctor] 11/2/2011 09:13

Says that ramper that was encouraging people to buy SAR at £50m and above

[clubman] 11/2/2011 09:11

I do not understand why any personal investor would throw their money down this hole.

Better buying Lotto tickets with you money, you would have more chance of a profit.